
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Don’t miss our latest news! Sign up today for our free newsletter.
By continuing to use our site, you agree to our Private Policy and Terms of Use.
HIV-positive adults who experience a discordant response to antiretroviral therapy'having either a fall in HIV viral load or a rise in CD4-cell count but not both'could be at a higher risk for AIDS-related complications and death. Canadian researchers reported in the November 1 edition of the Journal of Acquired Immune Deficiency Syndromes that after six months of therapy, HIVers who post only a drop in HIV viral levels to less than 500 or have only an increase in CD4-cell count to at least 50 cells were up to 21/2 times more likely to die than those responding fully to treatment. Patients with no response at all to treatment were nearly 31/2 times more likely to die. Overall, only 56% of the HIVers studied were complete responders; 15% posted only drops in viral loads, 12% experienced only CD4-cell increases, and 17% had neither. While many clinicians gauge responses to anti-HIV drug therapy by looking primarily at HIV viral levels, the researchers say their findings show that CD4-cell counts should be closely followed as well.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Don’t miss our latest news! Sign up today for our free newsletter.
Plus: Featured Video
Latest Stories
‘Kokomo City’ Gives a Searing Look Into Lives of Black Trans Sex Workers
August 18 2023 12:40 PM